Pages that link to "Q34377405"
Jump to navigation
Jump to search
The following pages link to Lipophosphoglycan of Leishmania major that vaccinates against cutaneous leishmaniasis contains an alkylglycerophosphoinositol lipid anchor (Q34377405):
Displaying 50 items.
- Golgi-located NTPDase1 of Leishmania major is required for lipophosphoglycan elongation and normal lesion development whereas secreted NTPDase2 is dispensable for virulence (Q28542765) (← links)
- GPI-anchored proteins and glycoconjugates segregate into lipid rafts in Kinetoplastida (Q32065261) (← links)
- Glycosphingolipid antigens of Leishmania (Leishmania) amazonensis amastigotes identified by use of a monoclonal antibody (Q33597411) (← links)
- Glycoconjugates in Leishmania infectivity (Q33778464) (← links)
- Parasite Carbohydrate Vaccines (Q33785863) (← links)
- Synthetic neoglycoconjugates of cell-surface phosphoglycans of Leishmania as potential anti-parasite carbohydrate vaccines (Q33870163) (← links)
- Developmental modification of lipophosphoglycan during the differentiation of Leishmania major promastigotes to an infectious stage (Q33938269) (← links)
- Leishmaniasis: current status of vaccine development (Q33941719) (← links)
- Chemical structure of Trichomonas vaginalis surface lipoglycan: a role for short galactose (β1-4/3) N-acetylglucosamine repeats in host cell interaction (Q34013409) (← links)
- Characterization of integral membrane proteins of Leishmania major by Triton X-114 fractionation and analysis of vaccination effects in mice (Q35111975) (← links)
- Lipophosphoglycan blocks attachment of Leishmania major amastigotes to macrophages. (Q35377451) (← links)
- The Mac-2 antigen is a galactose-specific lectin that binds IgE. (Q35596399) (← links)
- Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens (Q35812875) (← links)
- Differential Impact of LPG-and PG-Deficient Leishmania major Mutants on the Immune Response of Human Dendritic Cells (Q35859111) (← links)
- Down-Regulation of TLR and JAK/STAT Pathway Genes Is Associated with Diffuse Cutaneous Leishmaniasis: A Gene Expression Analysis in NK Cells from Patients Infected with Leishmania mexicana (Q35975567) (← links)
- A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan (Q36403849) (← links)
- Carbohydrate based vaccines (Q36456178) (← links)
- Leishmania promastigotes require opsonic complement to bind to the human leukocyte integrin Mac-1 (CD11b/CD18) (Q36530759) (← links)
- Leishmaniases of the New World: current concepts and implications for future research (Q36640255) (← links)
- Leishmania vaccines: progress and problems. (Q36726750) (← links)
- Identification of a macrophage-binding determinant on lipophosphoglycan from Leishmania major promastigotes (Q36752141) (← links)
- Study of Leishmania major-infected macrophages by use of lipophosphoglycan-specific monoclonal antibodies (Q36985810) (← links)
- Evidence of T-cell recognition in mice of a purified lipophosphoglycan from Leishmania major (Q37005098) (← links)
- Glycosylation in parasitic protozoa of the trypanosomatidae family (Q37072591) (← links)
- Leishmania dihydroxyacetonephosphate acyltransferase LmDAT is important for ether lipid biosynthesis but not for the integrity of detergent resistant membranes (Q37393018) (← links)
- Carbohydrate vaccines: developing sweet solutions to sticky situations? (Q37426039) (← links)
- Galactofuranose in eukaryotes: aspects of biosynthesis and functional impact. (Q37937329) (← links)
- Leishmaniasis: focus on the design of nanoparticulate vaccine delivery systems. (Q37965724) (← links)
- Leishmaniasis: vaccine candidates and perspectives (Q37999956) (← links)
- Vaccine Development Against Leishmania donovani (Q38012112) (← links)
- Leishmania chagasi: lipophosphoglycan characterization and binding to the midgut of the sand fly vector Lutzomyia longipalpis (Q38288829) (← links)
- Isolation and structural characterization of the Leishmania donovani kinetoplastid membrane protein-11, a major immunoreactive membrane glycoprotein (Q38300404) (← links)
- Leishmania cell wall as a potent target for antiparasitic drugs. A focus on the glycoconjugates (Q38541158) (← links)
- Delivery systems for Leishmania vaccine development (Q38746362) (← links)
- Structural analysis of a glycosylphosphatidylinositol glycolipid ofLeishmania donovani (Q39448021) (← links)
- Metabolic changes in glucose transporter-deficient Leishmania mexicana and parasite virulence (Q40278589) (← links)
- Immunostimulatory cellular responses of cured Leishmania-infected patients and hamsters against the integral membrane proteins and non-membranous soluble proteins of a recent clinical isolate of Leishmania donovani. (Q40447714) (← links)
- Cytokines in leishmaniasis: a complex network of stimulatory and inhibitory interactions. (Q40724088) (← links)
- The structure, biosynthesis and function of glycosylated phosphatidylinositols in the parasitic protozoa and higher eukaryotes (Q40847001) (← links)
- Inhibitory effects on protein kinase C activity by lipophosphoglycan fragments and glycosylphosphatidylinositol antigens of the protozoan parasite Leishmania (Q41265613) (← links)
- Glycoinositolphospholipids of Leishmania major inhibit nitric oxide synthesis and reduce leishmanicidal activity in murine macrophages (Q41365624) (← links)
- Characterization of a ricin-resistant mutant of Leishmania donovani that expresses lipophosphoglycan (Q41619990) (← links)
- Thy-1-specific helper T cells can provide intramolecular help, but can provide intermolecular help only if the phosphatidylinositol anchor of Thy-1 is replaced by a membrane insert (Q41729976) (← links)
- Cloning and structure-function analysis of the Leishmania donovani kinetoplastid membrane protein-11 (Q41788261) (← links)
- Identification of membrane dipeptidase as a major glycosyl-phosphatidylinositol-anchored protein of the pancreatic zymogen granule membrane, and evidence for its release by phospholipase A. (Q41822090) (← links)
- Activation of human T lymphocytes by Leishmania lipophosphoglycan (Q41882389) (← links)
- A simple purification of procyclic acidic repetitive protein and demonstration of a sialylated glycosyl-phosphatidylinositol membrane anchor. (Q42095439) (← links)
- Mapping of the antigenic determinants of the T. cruzi kinetoplastid membrane protein-11. Identification of a linear epitope specifically recognized by human Chagasic sera (Q42647252) (← links)
- Structural characterization of a novel glycosyl-phosphatidylinositol from the protozoan Tetrahymena mimbres (Q42862985) (← links)
- Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2. (Q44567637) (← links)